Erythropoiesis-Stimulating Agents (ESA's)

Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue. 

Falling Hemoglobin

Hemoglobin Adjustment

ESA's and Cardiac Impact

Hemoglobin of Ten is Sufficient

Clinical Experience with ESA's

Dose Adjustment

Product Comparison Aranesp and Procrit

Management of ESA's: CMS vs. MCO

Pricing Aranesp and Procrit

Rebates Aranesp and Procrit

Bundling: Rebates and Pricing

Prophylactic Use of ESA's

Liability Risk with use of ESA's

NCD Descussion

Denial of Off-Label

Length of Authorization

Avoid Transfusions

PA Criteria


* PTP video clips play in windows media player.  To download click here, Mac users click here
 

 

top of page